Mawson Infrastructure Group Inc. — Director's Dealing 2018

Jun 4, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2018-04-04

Reporting Person: Belkin Michael (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-04	Stock Option (right to buy)	$3.59	A	25000	Acquired	2025-04-04	Common Stock (25000)	Direct

Footnotes

F1: The Stock Option is exercisable in twelve equal installments over the three year period from the date of grant.

F2: The Stock Option was granted as compensation for services as a director of the Issuer.